Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

10.1097/FTD.0000000000000298

Saved in:

Bibliographic Details
Main Authors:	Lee, JW, Pussegoda, K, Rassekh, SR, Monzon, JG, Liu, G, Hwang, S, Bhavsar, AP, Pritchard, S, Ross, CJ, Amstutz, U, Carleton, BC, Hayden, MR, MacLeod, S, Smith, A, Brunham, L, Aminkeng, F, Shear, NH, Koren, G, Ito, S, Madadi, P, Rieder, MJ, Kim, R, Maher, M, Flockhart, D
Other Authors:	COMMUNITY,OCCUPATIONAL & FAMILY MEDICINE
Format:	Review
Published:	Ovid Technologies (Wolters Kluwer Health) 2022
Subjects:	Antineoplastic Agents Cisplatin Genetic Markers Hearing Loss Humans Pharmacogenetics Polymorphism, Genetic
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/235097
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-235097
record_format	dspace
spelling	sg-nus-scholar.10635-2350972024-04-17T09:53:31Z Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers Lee, JW Pussegoda, K Rassekh, SR Monzon, JG Liu, G Hwang, S Bhavsar, AP Pritchard, S Ross, CJ Amstutz, U Carleton, BC Hayden, MR MacLeod, S Smith, A Brunham, L Aminkeng, F Shear, NH Koren, G Ito, S Madadi, P Rieder, MJ Kim, R Maher, M Flockhart, D COMMUNITY,OCCUPATIONAL & FAMILY MEDICINE MEDICINE Antineoplastic Agents Cisplatin Genetic Markers Hearing Loss Humans Pharmacogenetics Polymorphism, Genetic 10.1097/FTD.0000000000000298 Therapeutic Drug Monitoring 38 4 423-431 2022-12-01T08:21:02Z 2022-12-01T08:21:02Z 2016-08-01 2022-11-30T18:26:23Z Review Lee, JW, Pussegoda, K, Rassekh, SR, Monzon, JG, Liu, G, Hwang, S, Bhavsar, AP, Pritchard, S, Ross, CJ, Amstutz, U, Carleton, BC, Hayden, MR, MacLeod, S, Smith, A, Brunham, L, Aminkeng, F, Shear, NH, Koren, G, Ito, S, Madadi, P, Rieder, MJ, Kim, R, Maher, M, Flockhart, D (2016-08-01). Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers. Therapeutic Drug Monitoring 38 (4) : 423-431. ScholarBank@NUS Repository. https://doi.org/10.1097/FTD.0000000000000298 0163-4356 1536-3694 https://scholarbank.nus.edu.sg/handle/10635/235097 Ovid Technologies (Wolters Kluwer Health) Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Antineoplastic Agents Cisplatin Genetic Markers Hearing Loss Humans Pharmacogenetics Polymorphism, Genetic
spellingShingle	Antineoplastic Agents Cisplatin Genetic Markers Hearing Loss Humans Pharmacogenetics Polymorphism, Genetic Lee, JW Pussegoda, K Rassekh, SR Monzon, JG Liu, G Hwang, S Bhavsar, AP Pritchard, S Ross, CJ Amstutz, U Carleton, BC Hayden, MR MacLeod, S Smith, A Brunham, L Aminkeng, F Shear, NH Koren, G Ito, S Madadi, P Rieder, MJ Kim, R Maher, M Flockhart, D Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
description	10.1097/FTD.0000000000000298
author2	COMMUNITY,OCCUPATIONAL & FAMILY MEDICINE
author_facet	COMMUNITY,OCCUPATIONAL & FAMILY MEDICINE Lee, JW Pussegoda, K Rassekh, SR Monzon, JG Liu, G Hwang, S Bhavsar, AP Pritchard, S Ross, CJ Amstutz, U Carleton, BC Hayden, MR MacLeod, S Smith, A Brunham, L Aminkeng, F Shear, NH Koren, G Ito, S Madadi, P Rieder, MJ Kim, R Maher, M Flockhart, D
format	Review
author	Lee, JW Pussegoda, K Rassekh, SR Monzon, JG Liu, G Hwang, S Bhavsar, AP Pritchard, S Ross, CJ Amstutz, U Carleton, BC Hayden, MR MacLeod, S Smith, A Brunham, L Aminkeng, F Shear, NH Koren, G Ito, S Madadi, P Rieder, MJ Kim, R Maher, M Flockhart, D
author_sort	Lee, JW
title	Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
title_short	Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
title_full	Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
title_fullStr	Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
title_full_unstemmed	Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
title_sort	clinical practice recommendations for the management and prevention of cisplatin-induced hearing loss using pharmacogenetic markers
publisher	Ovid Technologies (Wolters Kluwer Health)
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/235097
_version_	1800915744315146240

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

Similar Items